| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/24/2004 | EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 03/24/2004 | EP1399160A2 Nr2b receptor antagonists for the treatment or prevention of migraines |
| 03/24/2004 | EP1399157A1 Combination comprising a p-gp inhibitor and an anti-epileptic drug |
| 03/24/2004 | EP1399153A2 Pharmaceutical composition comprising a drug and a fatty acid or salt thereof |
| 03/24/2004 | EP1399152A1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester |
| 03/24/2004 | EP1399151A2 A method for treating inflammatory diseases by administering a ppar-delta agonist |
| 03/24/2004 | EP1399149A2 Taxane prodrugs |
| 03/24/2004 | EP1399134A2 Differential delivery of nitric oxide |
| 03/24/2004 | EP1399128A1 Composition for the treatment of diseases which affect animals' hooves |
| 03/24/2004 | EP1399113A1 Cosmetic or dermatological composition comprising n-acylaminoamide derivatives |
| 03/24/2004 | EP1399021A1 Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide |
| 03/24/2004 | EP1242087B1 Analgesic compositions containing buprenorphine |
| 03/24/2004 | EP1231934B1 Methods of inhibiting atrophy or promoting hypertrophy |
| 03/24/2004 | EP1150693B1 Immunogenic compositions for use as vaccines |
| 03/24/2004 | EP1121456A4 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
| 03/24/2004 | EP1033981B1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 03/24/2004 | EP0904079B1 Antidiabetic agents |
| 03/24/2004 | EP0869970B1 Endothelial cell proliferation inhibitor and its use |
| 03/24/2004 | EP0869773B1 Archaeosomes, archaeosomes containing coenzyme q 10, and other types of liposomes containing coenzyme q 10 as adjuvants and as delivery vehicles |
| 03/24/2004 | EP0819432B1 Antitumor agents comprising as the principal agent compounds containing silicon and nitrogen |
| 03/24/2004 | CN1484537A Pharmacentical preparation for douches and/or irrigations of natural or puthological cavities in human body |
| 03/24/2004 | CN1484533A Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis for the treatment and prevention of |
| 03/24/2004 | CN1484525A Combinations of drugs (E. G chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 03/24/2004 | CN1484524A 5-HT IA veceptor subtype agonist |
| 03/24/2004 | CN1484521A Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
| 03/24/2004 | CN1484494A Pesticidal and antiparasitic compositions |
| 03/24/2004 | CN1484493A 液体抗微生物组合物 Liquid antimicrobial composition |
| 03/24/2004 | CN1483478A Eye preparation formula adapted for therapentic medicine |
| 03/24/2004 | CN1483413A Medicinal composition for treationg virus infention of rlavivirus family, set group and packaged products |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/24/2004 | CN1142792C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 03/24/2004 | CN1142724C Two-stage preparation |
| 03/23/2004 | US6711436 Compositions, apparatus and methods for facilitating surgical procedures |
| 03/23/2004 | US6710087 For therapy and prophylaxis of disorders that are ameliorated by the inhibition of neuronal monoamine uptake in mammals; disorders including erectile dysfunction, affective disorders, obesity, cerebral function disorders, pain |
| 03/23/2004 | US6710068 Phenylsulfonylinodles useful for the treatment of hiv in humans and other host animals |
| 03/23/2004 | US6710063 Activators of PPAR delta |
| 03/23/2004 | US6710059 Methods of treating and/or suppressing weight gain |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710033 Treating with anti-chlamydial agents to improve or sustain neurological function |
| 03/23/2004 | US6710028 Method for treating disturbances in iron metabolism using a combination of erythropoietin and iron |
| 03/23/2004 | US6710026 Diabetes |
| 03/23/2004 | US6709864 Composition comprising isolated human mesenchymal stem cells in biocompatible matrix which supports differentiation and maturation of stem cells into adipocytes |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709679 Antineoplastic conjugates of transferin, albumin and polyethylene glycol |
| 03/23/2004 | US6709676 Bilayer solid comprising an immediate release first layer of desloratadine, and an antioxidant or group 2a or aluminum salts and excipient, and a sustained release second layer of nasal decongestant such as pseudoephedrine sulfate |
| 03/23/2004 | US6709663 Topical emulsion; quaternary ammonium salt emulsifier |
| 03/23/2004 | CA2350074C Aerosols comprising nanoparticle drugs |
| 03/18/2004 | WO2004023138A1 Method of screening remedy for aids |
| 03/18/2004 | WO2004022752A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 03/18/2004 | WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022538A1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022083A1 A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
| 03/18/2004 | WO2004022072A1 Boronic acid salts ant their use in the treatment of thrombosis |
| 03/18/2004 | WO2004022071A1 Multivalent metal salts of boronic acids for treating thrombosis |
| 03/18/2004 | WO2004022070A1 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition |
| 03/18/2004 | WO2004022068A1 A method of extending the dose range of vitamin d compounds |
| 03/18/2004 | WO2004022058A1 Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs |
| 03/18/2004 | WO2004022056A1 Medicinal composition and method for treating malignant tumor and utilization thereof |
| 03/18/2004 | WO2004022035A1 Water stabilized medicinal aerosol formulation related applications |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004022031A2 Stable probiotic microsphere compositions and their methods of preparation |
| 03/18/2004 | WO2004022002A2 Combined immediate release and extended release analgesic composition |
| 03/18/2004 | WO2004021992A2 Delivery of therapeutics to the brain and spinal cord |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004021972A2 Pharmaceuticals formulations and methods for modified release of statin drugs |
| 03/18/2004 | WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors |
| 03/18/2004 | WO2004007697A3 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 03/18/2004 | WO2004005286A3 Viral inhibitors |
| 03/18/2004 | WO2003099289A3 Compositions and their uses for alleviating pain |
| 03/18/2004 | WO2003092623A3 Calicheamicin derivative-carrier conjugates |
| 03/18/2004 | WO2003079972A3 Active agent delivery systems and methods for protecting and administering active agents |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |
| 03/18/2004 | WO2003072111A3 Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression |
| 03/18/2004 | WO2003070965A3 The eaat2 promoter and uses thereof |
| 03/18/2004 | WO2003066595A3 2 - piperazine - pyridines useful for treating pain |
| 03/18/2004 | WO2003065984A3 Methods and compositions for treating cardiovascular disease |
| 03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003041725A3 Regulation of cgmp-specific phosphodiesterase 9a |
| 03/18/2004 | WO2003041701A3 Preparation for improving the action of receptors |
| 03/18/2004 | WO2003039434A3 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002090567A9 Sperm-specific cation channel, and uses therefor |
| 03/18/2004 | WO2002076435A3 Lipid profile modulation with steroids |
| 03/18/2004 | US20040054480 Three dimensional structures and models of Fc receptors and uses thereof |
| 03/18/2004 | US20040054213 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2004 | US20040054180 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 03/18/2004 | US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040054014 Administering to subject at least one chemotherapeutic agent and at least one 3-aryloxy-3-phenylpropylamine; for multidrug resistance cancer |
| 03/18/2004 | US20040054012 Which can be utilized in injectable preparations being stable over a long period, and containing, for example, phenolic or polyphenolic substances, amino alcohols or sulphur-containing substances |
| 03/18/2004 | US20040054005 Sodium channel blocker compositions and the use thereof |